PT64907B - Procede de preparation d'une formulation a activite retarde - Google Patents

Procede de preparation d'une formulation a activite retarde

Info

Publication number
PT64907B
PT64907B PT64907A PT6490776A PT64907B PT 64907 B PT64907 B PT 64907B PT 64907 A PT64907 A PT 64907A PT 6490776 A PT6490776 A PT 6490776A PT 64907 B PT64907 B PT 64907B
Authority
PT
Portugal
Prior art keywords
preparing
delayed activity
activity formulation
formulation
delayed
Prior art date
Application number
PT64907A
Other languages
English (en)
Portuguese (pt)
Other versions
PT64907A (fr
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority claimed from KR7600645A external-priority patent/KR800001387B1/ko
Publication of PT64907A publication Critical patent/PT64907A/fr
Publication of PT64907B publication Critical patent/PT64907B/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT64907A 1975-03-17 1976-03-16 Procede de preparation d'une formulation a activite retarde PT64907B (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US65800376A 1976-02-13 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (2)

Publication Number Publication Date
PT64907A PT64907A (fr) 1976-04-01
PT64907B true PT64907B (fr) 1978-03-24

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
PT64907A PT64907B (fr) 1975-03-17 1976-03-16 Procede de preparation d'une formulation a activite retarde

Country Status (21)

Country Link
JP (1) JPS51115910A (fr)
AR (1) AR222624A1 (fr)
AT (1) AT353415B (fr)
AU (1) AU505355B2 (fr)
CA (1) CA1073358A (fr)
CH (1) CH630257A5 (fr)
DD (1) DD124102A5 (fr)
DE (1) DE2611041A1 (fr)
DK (1) DK148344C (fr)
ES (1) ES446075A1 (fr)
FR (1) FR2304354A1 (fr)
GB (1) GB1546448A (fr)
GR (1) GR60341B (fr)
IE (1) IE43083B1 (fr)
LU (1) LU74558A1 (fr)
MC (1) MC1101A1 (fr)
NL (1) NL190313C (fr)
NZ (1) NZ180321A (fr)
PH (1) PH14927A (fr)
PT (1) PT64907B (fr)
SE (1) SE433804B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
CH649215A5 (de) * 1981-04-29 1985-05-15 Hoffmann La Roche Pharmazeutische praeparate.
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
NL8600161A (nl) * 1985-02-05 1986-09-01 Sandoz Ag Farmaceutische preparaten die 9,10-dihydroergotalkaloiden bevatten.
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
NL194822C (nl) * 1985-10-01 2003-04-03 Novartis Ag Preparaat voor orale toediening met geregelde afgifte en werkwijze voor de bereiding ervan.
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
SK282071B6 (sk) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Tableta dispergovateľná vo vode a spôsob jej prípravy
JP2626248B2 (ja) * 1991-04-08 1997-07-02 日本新薬株式会社 カプセル剤
ATE173159T1 (de) * 1992-03-25 1998-11-15 Depomed Systems Inc Auf hydroxyethylzellulose basierende oralen arzneidosisformen mit verzoegerter wirkstoffabgabe
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
CN1133558A (zh) * 1993-10-29 1996-10-16 雷克特和科尔曼产品有限公司 可发泡的明胶胶囊填充药物
WO1995011667A1 (fr) * 1993-10-29 1995-05-04 R.P. Scherer Corporation Substance a pouvoir moussant garnissant une gelule de gelatine
WO1995031186A1 (fr) * 1994-05-13 1995-11-23 Smithkline Beecham Corporation Methode et composition accroissant la fixation du calcium
JPH10509981A (ja) * 1994-12-01 1998-09-29 サイバス ファーマシューティカル，インコーポレイティド 高等植物から得られうる粉末状親水コロイドゴムを用いる持効性薬剤送出
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
EP1245227A1 (fr) * 2001-03-31 2002-10-02 Jagotec Ag Comprimé pharmaceutique flottant dans l'estomac destiné à la libération programmée du principe actif et procédé pour produire le matériel flottant compris dans le comprimé
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
JPS5512411B2 (fr) * 1974-03-12 1980-04-02
DE2439538C3 (de) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe

Also Published As

Publication number Publication date
AR222624A1 (es) 1981-06-15
DD124102A5 (fr) 1977-02-02
IE43083L (en) 1976-09-17
DK148344B (da) 1985-06-17
DK113676A (da) 1976-09-18
FR2304354A1 (fr) 1976-10-15
DK148344C (da) 1985-11-04
FR2304354B1 (fr) 1979-04-27
JPS638084B2 (fr) 1988-02-19
AU505355B2 (en) 1979-11-15
AU1204976A (en) 1977-09-22
JPS51115910A (en) 1976-10-13
CA1073358A (fr) 1980-03-11
SE7603325L (sv) 1976-09-18
NL190313B (nl) 1993-08-16
GB1546448A (en) 1979-05-23
GR60341B (en) 1978-05-17
AT353415B (de) 1979-11-12
ATA192276A (de) 1979-04-15
NZ180321A (en) 1978-06-20
DE2611041A1 (de) 1976-10-14
ES446075A1 (es) 1977-09-16
MC1101A1 (fr) 1977-02-04
NL190313C (nl) 1994-01-17
NL7602776A (nl) 1976-09-21
LU74558A1 (fr) 1977-09-27
DE2611041C2 (fr) 1988-06-09
IE43083B1 (en) 1980-12-17
SE433804B (sv) 1984-06-18
PH14927A (en) 1982-01-29
CH630257A5 (en) 1982-06-15
PT64907A (fr) 1976-04-01

Similar Documents

Publication Publication Date Title
PT64907A (fr) Procede de preparation d'une formulation a activite retarde
LU80084A1 (fr) Procede de preparation d'oligoimides
BE840117A (fr) Procede de preparation d'hydroxybenzaldehydes
FR2314916A1 (fr) Procede de preparation d'urethannes aromatiques
BE839787A (fr) Procede de preparation d'isocyanates aliphatiques
RO70552A (fr) Procede de preparation des composes a activite hypolypemique
BE841285A (fr) Procede de preparation d'acetoacetyl-arylamides
FR2306199A1 (fr) Procede de preparation d'urethannes aromatiques
LU79019A1 (fr) Procede de preparation d'une composition pesticide a activite synergique
BE840452A (fr) Procede de preparation d'alkyleneglycols
BE864265A (fr) Procede de preparation d'acides alcoyl-carboxyliques superieurs
FR2309542A1 (fr) Procede de preparation d'acetoacetylamino-5 benzimidazolone
BE838736A (fr) Procede de preparation d'esters cyaniques aromatiques
BE842940A (fr) Procede de preparation d'oxaphospholannes-1,2,
BE840354A (fr) Procede de preparation d'agents therapeutiques
FR2315273A1 (fr) Procede de preparation d'indoloquinolizines
FR2322848A1 (fr) Procede de preparation d'un ester cyclopropane-carboxylique
FR2307781A1 (fr) Procede de preparation d'acenaphtenes
FR2309521A1 (fr) Procede de preparation d'esters alkylcarbamiques ou alcenylcarbamiques
FR2334654A1 (fr) Procede de preparation d'halogeno-nitrobenzenes
BE859970A (fr) Procede de preparation d'acides 2-carbamoylphosphiniques n-substitues
FR2322152B1 (fr) Procede de preparation d'acides epoxyalkylphosphoniques
FR2329642A1 (fr) Procede de preparation d'un dihalogenovinyl-cyclo-propane-carboxylate
BE843500A (fr) Procede de preparation d'oxaphospholannes-1,2,
BE850842A (fr) Procede de preparation d'acides naphtylaminosulfoniques